Key result
The miAfib app proves highly feasible for AFib patients, achieving ~95% daily symptom assessment adherence.
Why the study?
Symptoms related to atrial fibrillation are traditionally collected during clinic visits and are subject to recall bias over limited periods.
Is a mobile application (miAfib) feasible and usable for assessing daily symptoms and affect in patients with atrial fibrillation?
Is a mobile application (miAfib) feasible and usable for assessing daily symptoms and affect in patients with atrial fibrillation?
A mobile application for assessing daily symptoms and affect in patients with atrial fibrillation is feasible and highly acceptable to users.
Answers are grounded in this paper and cite their sources.
App-based daily AF symptom tracking feasible in small pilot; leaves open clinical utility and need for outcome trials.
BACKGROUND: Atrial fibrillation (AF) is the most prevalent arrhythmia leading to hospital admissions. The majority of patients with AF report symptoms that are believed to be associated with the arrhythmia. The symptoms related to AF traditionally are collected during a clinic visit that is influenced by biases associated with recalling the experience over a limited period of time. PURPOSE: We designed this pilot study to assess the usability and feasibility of a mobile application to assess symptoms in patients with AF. METHODS: We designed a mobile application (miAfib) to assess symptoms (chest pain, palpitation, shortness of breath, fatigue, dizziness/lightheadedness), positive affect (happy, excited, content) and negative affect (worried, angry, sad) on multiple occasions throughout the day based on iOS platform. We performed a four-week feasibility trial to examine user adherence, acceptance and experiences with the mobile application. We administered questionnaires to assess factors affecting usage and self-reported acceptance of the application based on a five-point Likert scale with zero representing strongly disagree and 5 representing strongly disagree with. RESULTS: We included ten patients with paroxysmal and persistent AF. The mean number of completed assessments each day was 2.81 ± 1.59 with 94.7% of days with at least one assessment. The users found the application easy to use (4.75±0.46), intended to use it in the future (4.37±1.06) and found it easy to integrate into daily routine (4.5±1.07). CONCLUSION: In this pilot study, we found participants in this four-week trial reliably used the application and were able to use the app to report their daily symptoms and affect regularly. Participants reported that they found the application easy to use and would consider using the application in the future.
No takes yet. Share an insight, caveat, or question.
Ghanbari et al. (2017) studied Atrial fibrillation (n=10). miAfib mobile application was evaluated on User adherence, acceptance and experiences. The miAfib mobile application was feasible and easy to use for patients with atrial fibrillation, with 94.7% of days having at least one symptom assessment over a 4-week period.
Synapse has enriched 10 related papers. Consider them for comparative context: